Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 24 (RPL29P24)

Target: RPL29P24
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L29 pseudogene 24 (RPL29P24) is a processed pseudogene in the human genome[1][5]. Although related by sequence to the functional ribosomal protein L29 gene (RPL29), it does not code for a protein and is not involved in ribosome assembly or function. Like many ribosomal protein pseudogenes dispersed throughout the genome, RPL29P24 does not contribute to protein synthesis or serve as a receptor, enzyme, transporter, or therapeutic target[1][5][3]. There is no established physiological or disease role for this pseudogene, and it does not interact with any known drugs.

Other names: RPL29_16_1290[5]

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 24 (RPL29P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 24 (RPL29P24).

Explore the full profile